Transaction overview

Lone Star Fund XII, L.P., a global private equity firm based in London, completed its acquisition of RadiciGroup’s High Performance Polymers and Specialty Chemicals businesses on April 30, 2026. The deal marks the culmination of Lone Star's efforts to form a leading independent tier-1 compounder with enhanced capabilities to serve diverse end markets.

The target businesses are part of RadiciGroup, an Italian chemical company renowned for producing high-performance polymers and specialty chemicals. These materials cater to various industries such as automotive, construction, consumer goods, and industrial applications. The transaction was first announced on February 1, 2025, setting the stage for Lone Star's strategic move into advanced material solutions.

Deal structure and financing

While specific financial details of the acquisition remain undisclosed, Lone Star has been known to leverage its extensive capital resources to execute complex transactions. Given the deal’s scope and Lone Star’s track record, it is likely that significant debt financing was secured through a consortium of investment-grade banks familiar with private equity-led acquisitions in the chemical sector.

The transaction structure aimed to create a fully independent entity under Lone Star's ownership, potentially involving a mix of debt and equity instruments. The acquisition could also include seller-financed arrangements, such as an earn-out or contingent consideration tied to future performance milestones. However, exact terms like leverage metrics, repayment schedules, and any retained stake by RadiciGroup are not publicly disclosed.

Strategic context

Lone Star’s rationale for acquiring the RadiciGroup businesses aligns with its long-term strategy of building a global platform capable of innovation in high-performance materials. By integrating RadiciGroup's capabilities into their existing portfolio, Lone Star aims to create a competitive advantage through enhanced product diversification and expanded market reach.

RadiciGroup’s divestiture reflects broader industry trends towards consolidating and streamlining operations under strategic ownership that can provide the necessary capital and operational expertise for growth. The acquisition also underscores the importance of sustainability in materials science as RadiciGroup has committed to offering recycled and bio-based solutions within its portfolio.

Regulatory path

The transaction required review from regulatory bodies across multiple jurisdictions due to the global nature of both Lone Star and RadiciGroup’s operations. Key regulators likely included those in Italy, where RadiciGroup is headquartered, as well as other countries with significant manufacturing or customer presence for the acquired businesses.

While no specific remedies were publicly announced, the deal was subject to standard antitrust filings under the Hart-Scott-Rodino (HSR) Act in the United States and equivalent regulations in Europe. The timeline for regulatory approval suggests a thorough vetting process given the complexity of integrating operations across different regions and product lines.